To the editor
=============

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematological disorders, characterized by ineffective hematopoiesis and a high risk of transformation into acute myeloid leukemia. It has been determined that oxidative stress plays a role in the initialization and disease progression \[[@B1]\]. The reactive oxygen species may oxidize tetrahydrobiopterin resulting into nitric oxide synthase (NOS) uncoupling and preferential formation to superoxide anion radical. It was found that methylarginines (asymmetric dimethylarginine - ADMA, N^G^-monomethyl-L-arginine - MMA and symmetric dimethylarginine - SDMA), naturally occurring inhibitors of NOS \[[@B2]\], can profoundly increase superoxide generation from uncoupled NOS \[[@B3]\]. Free methylated arginines, capable of inhibiting NOS \[[@B4]\], are formed exclusively by the sequence of methylation of arginine residues of proteins, followed by proteolysis of these proteins. Protein arginine methylation is in mammalian cells carried out by protein arginine methyltransferases (PRMTs); many of them show links to cancer \[[@B5]\].

The subjects of the study are characterized in Table [1](#T1){ref-type="table"}. Ethics approval (Ethics Committee of the Institute of Hematology and Blood Transfusion) and informed consent from all subjects were obtained. Serum concentration of oxidative stress marker malondialdehyde (MDA) was estimated using liquid chromatography (Shimadzu, Tokyo, Japan) of its thiobarbituric acid derivative \[[@B6]\]. Methylated arginines were analyzed using HILIC chromatography with MS/MS detection (ABSciex, Framingham, USA) \[[@B7]\]. Nitrites were assayed by chromatography using the fluorescent reaction product with 2,3-diaminonaphthalene \[[@B8]\].

###### 

Baseline characteristics of MDS patients and healthy controls

                                     **MDS**         **Controls**
  ---------------------------- -------------------- ---------------
  ^a^Age (years)                  43.7 (33--59)      44.3 (37--67)
  Male/Female                          11/9               8/8
  ^a^Serum iron \[μmol/L\]       22.3 (11.4-43.3)      ^b^8.5-28
  ^a^Serum ferritin \[μg/L\]    641.2 (8.9-1907.3)     ^b^15-150

^a^The data are depicted as averages with ranges. ^b^Reference interval.

The concentrations of methylated arginine derivatives, malondialdehyde and nitrites are summarized in the Table [2](#T2){ref-type="table"}. We found significantly increased serum concentrations of ADMA, SDMA, MMA, and MDA in sera of MDS patients as compared with healthy donors. The nitrites concentrations were significantly decreased in sera of MDS patients as compared with controls. The concentration of ADMA strongly positively correlated with concentration of MMA (r = 0.87, p \< 0.001) and SDMA (r = 0.70, p \< 0.001). ADMA concentration moderately positively correlated with MDA concentration (r = 0.50, p = 0.006).

###### 

Concentrations of methylated arginines in sera of MDS patients and healthy controls

                                **MDS**      **Controls**    ^**a**^**p**
  ------------------------- --------------- --------------- ---------------
  ADMA \[μmol/L\]             0.84 ± 0.32     0.56 ± 0.16     0.0022\*\*
  SDMA \[μmol/L\]             0.54 ± 0.18     0.42 ± 0.14      0.0361\*
  MMA \[μmol/L\]              0.14 ± 0.05     0.10 ± 0.03       0.033\*
  Homoarginine \[μmol/L\]     1.77 ± 1.06     2.32 ± 1.26       0.1777
  Citrulline \[μmol/L\]      46.68 ± 14.96   42.19 ± 12.31      0.3298
  MDA \[μmol/L\]              0.77 ± 0.11     0.52 ± 0.07    \<0.001\*\*\*
  Nitrites \[μmol/L\]         1.71 ± 0.46     2.16 ± 0.38     0.0028\*\*

The data are represented as averages ± SD. ADMA, N^G^, N^G^-dimethyl-L-arginine; MMA, N^G^-monomethyl-L-arginine; SDMA, N^G^,N^G'^-dimethyl-L-arginine; MDA, malondialdehyde. ^a^Two-tailed *t*-test was used to compare measured concentrations of analytes in MDS patients with healthy donors. Statistical significance coding: \* p \< 0.05, \*\* p \< 0.01 and \*\*\* p \< 0.001.

Our results showed significantly increased oxidative stress even in MDS patients characterized by moderately enhanced iron and serum transferrin concentrations. Resulting shift of overexpressed \[[@B9]\] NO synthase activity in favour of superoxide production at the expense of nitric oxide synthesis (reflected by nitrites concentrations \[[@B10]\]) was further augmented at the presence of methylated arginines. Therefore, oxidative stress in MDS patients could be explained by a positive feedback of both superoxide and methylated arginines on original NOS activity impairment. Moreover, recently proposed PRMT-specific inhibitors \[[@B11]\] might have a therapeutic effect on leukemia also by oxidative stress reduction.
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